Related Experiment Video
Updated: Mar 22, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation
Peter G Linde1, Patrick Archdeacon2, Matthew D Breyer3
1AbbVie, Inc., Global Pharmaceutical Research and Development, North Chicago, Illinois; peter.linde@abbvie.com ronald_falk@med.unc.edu.
Innovation in kidney disease research lags due to underfunded, disenfranchised patient populations and inadequate infrastructure. Addressing these requires improved understanding, patient engagement, and clinical trial support, with initiatives like the Kidney Health Initiative offering a path forward.
Area of Science:
- Nephrology
- Translational Medicine
- Health Services Research
Background:
- Kidney diseases significantly impact global health and mortality, yet research innovation lags behind other major therapeutic areas.
- A key barrier is the disproportionate effect on disenfranchised populations, leading to insufficient advocacy, public attention, and funding for nephrology research.
- The research infrastructure supporting nephrology is underdeveloped compared to specialties like cardiology and oncology.
Purpose of the Study:
- To identify and address the deficits hindering innovation in kidney disease research.
- To propose solutions for improving the understanding of disease mechanisms, patient engagement, and clinical trial infrastructure in nephrology.
- To highlight the role of collaborative initiatives in overcoming barriers to innovation.
Main Methods:
- The study identifies key areas requiring development: understanding disease pathophysiology, enhancing patient engagement, improving clinical trial infrastructure, and refining trial designs.
- It emphasizes the need for coordinated efforts among stakeholders.
- The Kidney Health Initiative is presented as a platform for addressing these challenges.
Main Results:
- Significant disparities exist in research funding and infrastructure for kidney diseases compared to other conditions.
- Patient engagement and activism are crucial but underdeveloped components of nephrology research.
- Existing clinical trial infrastructure and designs require substantial improvement to accelerate innovation.
Conclusions:
- Overcoming the innovation deficit in nephrology requires a multi-faceted approach addressing systemic inequities.
- Enhanced understanding of disease mechanisms, robust patient engagement, and modernized clinical trial frameworks are essential.
- Collaborative platforms like the Kidney Health Initiative are vital for driving future advancements in kidney disease research and treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention

